At Aurigene Pharmaceutical Services, we offer a wide range of integrated discovery biology services to meet your drug discovery needs. We offer end-to-end services including in vitro biology, ADME & DMPK studies, Toxicology, in vivo pharmacology and microbiology testing.
We provide integrated and standalone drug discovery services ranging from target identification to candidate nomination and further extension up to development services. Our best-in-class discovery biology services are supported by AAALAC accredited vivarium, BSL-2 compliant labs, in vivo facilities, GLP and other regulatory bodies accredited toxicology labs. Our discovery biology team offers a blend of scientific skills and pharmaceutical industry expertise with a proven track record of complex problem-solving capabilities. Biologists holding Masters, PhDs, and Postdocs are trained to undertake the most demanding drug discovery biology projects.
During the past two decades, the team in collaboration with our clients has been able to apply differentiated solutions to each aspect of drug discovery research, which has resulted in the discovery of many clinical candidates. Numerous research publications and feedback from clients are a testimony of our success.
In vitro Biology
Our team provides a wide range of services in biochemical assays, mechanistic assays, functional assays, immunological assays and various customized assays.
Drug Metabolism and Pharmacokinetics (DMPK)
We provide precise data and insightful analysis of a drug's absorption, distribution, metabolism and excretion (ADME) properties. These insights help the clients to shortlist compounds with a high likelihood of success in later stages of drug development. DMPK tests include:
- Physicochemical parameters
- Metabolism studies
- Permeability
- Distribution
- Drug-drug interactions
- Pharmacokinetics
- Bioanalysis
In vivo Pharmacology Studies
Our in vivo pharmacology team has expertise across multiple therapeutic areas. The team is supported by an AAALAC accredited, GLP-certified vivarium and experienced scientists who can set up diverse efficacy models as per program or client needs. We offer target engagement and efficacy models for:
- Oncology and immuno-oncology
- Metabolic disorders
- Inflammation
- Pain
- Acute inflammation
- Auto-immune disorders
- Syngeneic tumor
- Muscle regeneration
- Skin disorders
These are validated with reference compounds and supported by histopathology and biomarker analysis.
Pharmaceutical Microbiology Testing
Our pharmaceutical microbiology testing department has a BSL-2 compliant lab and a dedicated in vivo facility for bacterial and fungal infection murine disease models. Our team has vast experience in anti-infective drug discovery biology projects. The team has worked on several collaboration projects with innovator pharma companies to discover antibacterial and antifungal agents. We have also established in-vitro time-kill kinetics bioequivalence assays of generic products for regulatory submission.
Toxicology
We offer a full range of exploratory and GLP toxicology studies supported by clinical and anatomic pathology services, formulation analysis, toxicokinetic analysis and interpretation and reporting. General toxicology studies range from single-dose and repeat dose toxicology studies, genetic toxicology and IND and NDA enabling safety toxicology packages. We have a track record of successfully filing INDs using the in-house data with US FDA, MHRA, EMA, DCGI and ANDAs.
Why Aurigene Drug Discovery Biology Services?
Expert team of scientists
65+ IDD projects delivered
State-of-the-art facilities
US FDA inspected labs with zero 483 observations
AAALAC accredited animal house
NGCMA accreditation
Other Services
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
ADME/DMPK Services
In vivo Pharmacology
Microbiology Testing
Toxicology Studies
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Learning Resources
“Bathtub Chemistry” - Necessity and Aspects of Process Research
Medicine is an essential part of our life. Since ancient time human civilization has been tirelessly engaged to understand the cause and effect of a disease. Sometimes they win and many times they lose. But the story of their curiosity and enthusiasm is a never damping process. On the contrary it increases day by day, year after year.Drug discovery is a vast and ...
Read More
Accelerating Drug Discovery Through Innovative Partnerships
Genomics plays a vital role in identifying which gene is associated with a specific disease. A gene called CNOT1 is for example known for it's effect on brain development and for impairing memory and learning. Despite the great promise genomics provides in understanding the disease, genes are not the best drug targets....
Read More
Discovery, Development and Manufacturing Services
Aurigene Pharmaceutical Services is a leading contract research, development and manufacturing organization which provides range of services to enable your IND/NDA filing ...
Read More
Solid dispersion development to enhance solubility and oral bioavailability for rodent toxicology studies
Background: Develop oral liquid dosage form of an IND candidate (small molecule) suitable for chronic toxicology studies in rats. Must meet required systemic exposure and shall be dose proportional. Developed vehicle or used excipients shall be safe for chronic preclinical toxicology studies. Challenges: Low oral bioavailability Practically insoluble in bio relev...
Read More
Revisiting the reaction of b-chloroacroleins with 2-aminophenol: a new observation
2008
The reaction of b-chloroacrolein with 1 equiv of 2-aminophenol in DMF proceeds smoothly to afford 11-hydroxy derivative of chromenoquinoline in good yield. This single pot method allows for a rapid access to a variety of chromenoquinolines or oxepinoquinolines depending on the nature of b-chloroacrolein used. The structures were established by spectroscopic data ...
Read More-
Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques
Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read More -
Development of novel paullone-based PROTACs as anticancer agents
Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read More -
Development and verification of RP-HPLC method for the quantitative determination of Decitabine in tablet dosage formulation
Decitabine is an anti-cancer chemotherapy drug. This article describes method development and method verification of Assay of Decitabine in tablet formulation. A new, precise, rapid, accurate RP-HPLC method has been developed for the estimation of Decitabine in pharmaceutical tablets dosage form. After optimization the good chromatographic separation was achieved...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market